Global sales of GLP-1 medications are predicted to reach $133 billion by 2030, according to MarketWatch
Such components are closely linked to a high incidence of cardiovascular disease (CVD) and heart failure (HF), resulting in elevated mortality rates and soaring healthcare costs (4, 5)
The therapy may take at least three months of daily treatment to be effective
Dr Jim Hungerford, CEO of the Butterfly Foundation, says weight-loss medications are marketed as a quick fix, making them extremely attractive to people with eating disorders, but they can have tragic consequences
Formulada y Fabricada Exclusivamente para: LargeLife Ltd., Enterprise House, 2 Pass Street, Oldham, Manchester, OL9 6HZ, United Kingdom.
Without a foundation, nothing sticks